Ryan M. Bartolucci Sells 6,059 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) CAO Ryan M. Bartolucci sold 6,059 shares of the stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $80.00, for a total transaction of $484,720.00. Following the transaction, the chief accounting officer now owns 47,000 shares in the company, valued at $3,760,000. The trade was a 11.42 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Tempus AI Stock Performance

Shares of Tempus AI stock opened at $89.44 on Friday. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The business has a fifty day simple moving average of $46.60 and a two-hundred day simple moving average of $50.32. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $91.45.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on TEM shares. Loop Capital cut their target price on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday, January 14th. Piper Sandler restated a “neutral” rating and issued a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. William Blair cut shares of Tempus AI from an “outperform” rating to a “market perform” rating in a report on Wednesday. Needham & Company LLC reaffirmed a “buy” rating and issued a $56.00 price target on shares of Tempus AI in a research note on Tuesday, January 14th. Finally, Bank of America raised their price target on Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research note on Friday, December 13th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $58.55.

Hedge Funds Weigh In On Tempus AI

Several institutional investors and hedge funds have recently added to or reduced their stakes in TEM. IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new position in Tempus AI during the third quarter valued at $258,000. Clarus Group Inc. purchased a new position in Tempus AI during the third quarter valued at $283,000. International Assets Investment Management LLC raised its position in shares of Tempus AI by 141,400.0% in the 3rd quarter. International Assets Investment Management LLC now owns 70,750 shares of the company’s stock worth $4,004,000 after purchasing an additional 70,700 shares during the last quarter. Dakota Wealth Management purchased a new position in shares of Tempus AI in the 3rd quarter worth about $1,185,000. Finally, Janney Capital Management LLC purchased a new position in shares of Tempus AI in the 3rd quarter worth about $385,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.